NCT01651442View on ClinicalTrials.gov

Sequenced Therapies for Comorbid and Primary Insomnias

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

August 1, 2012

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions
Insomnia Comorbid to Psychiatric DisorderPrimary Insomnia
Interventions
BEHAVIORAL

Behavioral Insomnia Therapy

Sleep hygiene, stimulus control, and sleep restriction presented in four sessions.

DRUG

Zolpidem

5mg or 10mg

DRUG

Trazodone

50mg to 150mg

BEHAVIORAL

Cognitive Therapy

Cognitive restructuring, constructive worry, behavioral experiments presented in four sessions.

Trial Locations (2)

80206

National Jewish Health, Denver

Unknown

Université Laval, Québec

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Jack Edinger, PhD

OTHER

NCT01651442 - Sequenced Therapies for Comorbid and Primary Insomnias | Biotech Hunter | Biotech Hunter